An implantable centrifugal blood pump for long term circulatory support

被引:18
作者
Yamazaki, K
Litwak, P
Kormos, RL
Mori, T
Tagusari, O
Antaki, JF
Kameneva, M
Watach, M
Gordon, L
Umezu, M
Tomioka, J
Koyanagi, H
Griffith, BP
机构
[1] SUN MED TECHNOL RES CORP,SUWA NAGANO,JAPAN
[2] WASEDA UNIV,TOKYO,JAPAN
[3] TOKYO WOMENS MED COLL,TOKYO 162,JAPAN
关键词
D O I
10.1097/00002480-199709000-00072
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
A compact centrifugal blood pump was developed as an implantable left ventricular assist system. The impeller diameter is 40 mm and the pump dimensions are 55 x 64 mm. This first prototype was fabricated from titanium alloy, resulting in a pump weight of 400 g including a brushless DC motor. Weight of the second prototype pump was reduced to 280 g. The entire blood contacting surface is coated with diamond like carbon to improve blood compatibility. Flow rates of over 7 L/min against 100 mmHg pressure at 2,500 rpm with 9 W total power consumption have been measured. A newly designed mechanical seal with a recirculating purge system (''Cool-Seal'') is used as a shaft seal. In this seal system, seal temperature is kept under 40 degrees C to prevent heat denaturation of blood proteins. Purge fluid also cools the pump motor coil and journal bearing. The purge fluid is continuously purified and sterilized by an ultrafiltration filter incorporated into the paracorporeal drive console. In vitro experiments with bovine blood demonstrated an acceptably low hemolysis rate (normalized index of hemolysis = 0.005 +/- 0.002 g/100 L). In vivo experiments are currently ongoing using calves. Via left thoracotomy, left ventricular apex-descending aorta bypass was performed utilizing a PTFE (Polytetrafluoroethylene) vascular graft, with the pump placed in the left thoracic cavity. In two in vivo experiments, pump flow rate was maintained at 5-8 L/min, and pump power consumption remained stable at 9-10 W. All plasma free hemoglobin levels were measured at <15 mg/dl. The seal system has demonstrated good seal capability with negligible purge fluid consumption (<0.5 ml/day). Both animals remain under observation after 162 and 91 days of continuous pump function.
引用
收藏
页码:M686 / M691
页数:6
相关论文
共 7 条
[1]   CENTRIFUGAL BLOOD PUMP WITH A MAGNETICALLY SUSPENDED IMPELLER [J].
AKAMATSU, T ;
NAKAZEKI, T ;
ITOH, H .
ARTIFICIAL ORGANS, 1992, 16 (03) :305-308
[2]  
BUTLER KC, 1992, ASAIO J, V38, P296
[3]  
Dion I., 1993, Bio-Medical Materials and Engineering, V3, P51
[4]   SYSTEM CONSIDERATIONS FAVORING ROTARY ARTIFICIAL HEARTS WITH BLOOD-IMMERSED BEARINGS [J].
JARVIK, RK .
ARTIFICIAL ORGANS, 1995, 19 (07) :565-570
[5]   DEVELOPMENT OF AN AXIAL-FLOW VENTRICULAR ASSIST DEVICE - IN-VITRO AND IN-VIVO EVALUATION [J].
MIZUGUCHI, K ;
DAMM, G ;
BENKOWSKY, R ;
ABER, G ;
BACAK, J ;
SVJKOVSKY, P ;
GLUECK, J ;
TAKATANI, S ;
NOSE, Y ;
NOON, GP ;
DEBAKEY, ME .
ARTIFICIAL ORGANS, 1995, 19 (07) :653-659
[6]   THE NEXT-GENERATION BAYLOR C-GYRO PUMP - ANTITHROMBOGENIC FREE IMPELLER DESIGN FOR LONG-TERM CENTRIFUGAL VAD [J].
OHARA, Y ;
NOSE, Y .
ARTIFICIAL ORGANS, 1994, 18 (03) :238-243
[7]  
WAKISAKA Y, 1995, AM SOC INTERN ORGANS, V41, P350